Laryngeal Mask Airways Are Supraglottic Devices Used to Maintain Airway Patency During Anesthesia and in Difficult Airways. IV Dexmedetomidine Improves LMA Insertion Success and Decreases Coughing, While IV Lidocaine Decreases Postoperative Cough.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-12
SponsorAssiut University

About this trial

Laryngeal Mask Airways Are Supraglottic Devices Used to Maintain Airway Patency During Anesthesia and in Difficult Airways. LMA may help in reducing postoperative pulmonary complications. IV Dexmedetomidine Improves LMA Insertion Success and Decreases trials number, While IV Lidocaine Decreases Postoperative Cough. This is a randomized interventional trial comparing both drugs. IV DEX will be compared vs IV lidocaine regarding the feasibility of insertion, number of trials, incidence of cough, postoperative pulmonary complications and hemodynamic profile.

Eligibility criteria

Qualifiers

Parental/guardian consent.

Age 2-12 years

ASA physical status I-II.

Elective surgery requiring LMA (duration <2 hours).

Disqualifiers

Known airway anomalies (e.g., tonsillar hypertrophy, cleft palate).

Cardiovascular disease (bradycardia, arrhythmias).

Allergy to study drugs.

BMI >95th percentile.

Trial design

Treatments tested in this trial

  • Dexamedomedine
  • Lidocaine (drug)

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators